Tetra Bio-Pharma Inc. JAM1.F Stock
Tetra Bio-Pharma Inc. Price Chart
Tetra Bio-Pharma Inc. JAM1.F Financial and Trading Overview
| Tetra Bio-Pharma Inc. stock price | 0.01 EUR |
| Previous Close | 0.01 EUR |
| Open | 0.01 EUR |
| Bid | 0 EUR x 4074100 |
| Ask | 0 EUR x 2558200 |
| Day's Range | 0.01 - 0.01 EUR |
| 52 Week Range | 0.0046 - 0.07 EUR |
| Volume | 3.8K EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 7.32M EUR |
| Beta (5Y Monthly) | 2.204425 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
JAM1.F Valuation Measures
| Enterprise Value | 6.47M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.529 |
Trading Information
Tetra Bio-Pharma Inc. Stock Price History
| Beta (5Y Monthly) | 2.204425 |
| 52-Week Change | -58.88% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.07 EUR |
| 52 Week Low | 0.0046 EUR |
| 50-Day Moving Average | 0.01 EUR |
| 200-Day Moving Average | 0.02 EUR |
JAM1.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 423.36M |
| Float | 418.75M |
| Short Ratio | N/A |
| % Held by Insiders | 0.99% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | November 30, 2021 |
| Most Recent Quarter (mrq) | August 31, 2022 |
| Next Fiscal Year End | November 30, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -38.52% |
| Return on Equity (ttm) | -315.85% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -12226938 EUR |
| Net Income Avi to Common (ttm) | -39017704 EUR |
| Diluted EPS (ttm) | -0.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 483.2K EUR |
| Total Cash Per Share (mrq) | 0.001 EUR |
| Total Debt (mrq) | 1.66M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.252 |
| Book Value Per Share (mrq) | -0.014 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8184342 EUR |
| Levered Free Cash Flow (ttm) | -3517075 EUR |
Profile of Tetra Bio-Pharma Inc.
| Country | Germany |
| State | ON |
| City | Orléans |
| Address | 2316 St. Joseph Boulevard |
| ZIP | K1C 1E8 |
| Phone | N/A |
| Website | https://www.tetrabiopharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 33 |
Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. Tetra Bio-Pharma Inc. has an agreement with Cellvera Global Holdings LLC for the co-development of ARDS-003 as a combination product with Qifenda 400MG (Favipiravir), a commercial-stage broad-spectrum antiviral drug. The company is headquartered in Orléans, Canada.
Q&A For Tetra Bio-Pharma Inc. Stock
What is a current JAM1.F stock price?
Tetra Bio-Pharma Inc. JAM1.F stock price today per share is 0.01 EUR.
How to purchase Tetra Bio-Pharma Inc. stock?
You can buy JAM1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Tetra Bio-Pharma Inc.?
The stock symbol or ticker of Tetra Bio-Pharma Inc. is JAM1.F.
Which industry does the Tetra Bio-Pharma Inc. company belong to?
The Tetra Bio-Pharma Inc. industry is Biotechnology.
How many shares does Tetra Bio-Pharma Inc. have in circulation?
The max supply of Tetra Bio-Pharma Inc. shares is 585.28M.
What is Tetra Bio-Pharma Inc. Price to Earnings Ratio (PE Ratio)?
Tetra Bio-Pharma Inc. PE Ratio is 0.00000000 now.
What was Tetra Bio-Pharma Inc. earnings per share over the trailing 12 months (TTM)?
Tetra Bio-Pharma Inc. EPS is 0 EUR over the trailing 12 months.
Which sector does the Tetra Bio-Pharma Inc. company belong to?
The Tetra Bio-Pharma Inc. sector is Healthcare.